the role of targeted therapies in her2 and hr breast cancer
Published 9 months ago • 177 plays • Length 0:41Download video MP4
Download video MP3
Similar videos
-
10:08
evolving role of her2 targeted therapies in gastroesophageal cancers
-
0:59
sequencing her2-targeted therapies in breast cancer
-
4:52
3-year dfs in randomized trials of chemotherapy and her2-targeted therapy
-
0:30
the role of serds in the treatment landscape of patients with er /her2- breast cancer
-
3:32
sequencing novel her2-targeted therapies in metastatic breast cancer
-
4:45
evolving role of her2-targeted therapy in breast cancer
-
2:01
the latest developments in targeted therapies for breast cancer
-
4:53
comparing therapy benefit from initially her2 positive or negative metastatic breast cancer patients
-
3:15
investigating targeted therapy combinations in metastatic hr breast cancer
-
0:57
evaluating the benefits of selective cdk4 inhibition in hr /her2- breast cancer
-
2:15
outlook for hr /her2- advanced breast cancer treatment
-
1:14
the importance of a biomarker-directed approach in triple-negative breast cancer
-
0:34
future role of immunotherapy in her2 breast cancer
-
1:19
targeted therapies for patients with her2 colorectal cancer
-
1:05
the genomic characterization of primary and metastatic her2-low breast cancers
-
0:35
key challenge associated with the management of hr /her2- breast cancer
-
2:06
unmet needs and cdk4/6 inhibitors in hr /her2- early breast cancer
-
3:58
novel targeted therapies in breast cancer
-
4:37
predict underestimates survival of patients with her2 early breast cancer